GlassScriptPhysician profile
Pittman D Moore
NPI 1811018880
$1,949.54
in general payments reported to CMS, 2019-2025
21 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.98 · 2020: $81.98 · 2021: $226 · 2022: $297 · 2023: $919 · 2024: $61.74 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $664 · Travel and Lodging: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.89 |
| Travel and Lodging | $620.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $744.06 | 2023 | Da Vinci Surgical System |
| Merz North America, INC. | $414.61 | 2021-2022 | |
| Hologic Sales and Service, LLC | $141.77 | 2023-2024 | Myosure Tissue Removal Device, Thinprep 2000 Processor, Aptima |
| Baxter Healthcare | $113.56 | 2025 | Perclot |
| Boston Scientific Corporation | $83.87 | 2025 | Solyx Sis System, Wavewriter Alpha Prime 16, Axonics |
| Axonics, INC. | $58.89 | 2020-2023 | Axonics |
| Minerva Surgical, INC | $53.13 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $46.10 | 2025 | |
| Olympus America INC. | $39.97 | 2019 | |
| Baudax Bio INC. | $38.44 | 2020 | |
| Gilead Sciences, INC. | $32.68 | 2021 | |
| Medtronic USA, INC. | $28.14 | 2020 | |
| Biogen, INC. | $23.26 | 2025 | Zurzuvae |
| Ethicon US, LLC | $20.01 | 2019 | |
| Smith+Nephew, INC. | $19.11 | 2025 | Allevyn Life L 15.4x15.4 Ctn10 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $17.64 | 2025 | Prevena |
| Coloplast Corp | $17.37 | 2024 | |
| Novo Nordisk INC | $15.83 | 2024 | |
| Convatec INC. | $14.03 | 2023 | |
| Sumitomo Pharma America, INC. | $13.69 | 2024 | Myfembree |
| Antares Pharma, INC. | $13.38 | 2023 | Tlando, Xyosted, Nocdurna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pittman Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.